Patent · US Active

Bifunctional molecules for inactivating HIV and blocking HIV entry

US8828932B2 · kind B2 · utility

0Cited by

3References

3Claims

0Family size

Assignee

New York Blood Center, Inc. · US

Inventors

Shibo Jiang · Floral Park, US
Chungen Pan · Floral Park, US
Lu Lu · San Diego, US

Key dates

Filing date	May 3, 2011
Grant date	Sep 9, 2014
Priority date	—
Expiry date	Mar 14, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2740/16122
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are bifunctional molecules which inactivate human immunodeficiency virus (HIV) even before the virus attacks the target cell and inhibits HIV entry into the target cell. Also disclosed are novel anti-HIV therapeutics for treatment of patients infected by HIV. Further disclosed are methods for prophylaxis against HIV and treatment of HIV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.